Pete Finan is the former head of the Novartis Institute of BioMedical Research (NIBR) site in the UK where he oversaw the activities of 350 scientists and clinicians working in the respiratory disease area. Prior to this he was an Executive Director in the Developmental and Molecular Pathways department at NIBR in Cambridge, Massachusetts leading programs in oncology, inflammation and regenerative medicine and Head of Biology at Karus Therapeutics. Pete is also a Partner at Epidarex Capital and has led / co-led the financing of six new companies in the Epidarex portfolio. He has a BSc and PhD from the University of Leeds.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Leucid Bio | Board Member | Oct 1, 2021 | — | Detail |